Sentences with phrase «of smaller biotech companies»

The reason some hiring managers are more critical of industry postdocs is that a number of smaller biotech companies consider positions at the postdoc level to be «cheap pairs of hands» jobs and not independent research positions.

Julian was also CEO of a small biotech company.

«A lot of small biotech companies have been affected by the economic situation.

Not exact matches

On average, the 30 large and small pharmaceutical and biotech companies IDEA Pharma examined got just 11 % of their 2017 revenue from drugs developed within the past five years, says Mike Rea, the firm's CEO and one of the most insightful people I've met — no exaggeration — when it comes to pinpointing innovation choke points in the drug industry.

The «microbiome,» or the collection of organisms that reside within the human body (especially the gut), has become a big new interest area for a number of major pharma companies like Merck and smaller biotechs alike.

The head of Riot Blockchain, a small biotech company - turned - crypto, has made hundreds of thousands of dollars in stock sales already.

Says biotech recruiter Jackie Bandish: «For many of these guys, a small company can be a breath of fresh air.»

• Ribometrix Inc, a Greenville, N.C. - based biotech company focused on developing small molecule modulators of RNA to treat disease, raised $ 7.5 million in seed funding.

This part of the market, typically made up of small technology and biotech companies, often struggles to attract investors because people prefer the safety of owning shares in larger companies.

In his Transformational Technology Alert research advisory, Patrick Cox leverages his over 30 years of experience as a consultant, writer, and researcher in the tech / biotech space to bring to you the small - cap tech and medical companies with the potential to transform our lives.

Although drugs are only a small fraction of the total cost of healthcare, pharmaceutical and biotech companies have been increasingly criticized, especially during election cycles.

What Stephen Hawking Missed: Small Biotechs Developing Promising Cell Therapies for Devastating Disease Source: Streetwise Reports (5/2/18) In the second of a two - part series exploring the disruptive cell therapy space, Maxim Group analyst Jason McCarthy takes a look at small - cap companies targeting big - ticket indications and their potential to drive blockbuster value for both patients and invesSmall Biotechs Developing Promising Cell Therapies for Devastating Disease Source: Streetwise Reports (5/2/18) In the second of a two - part series exploring the disruptive cell therapy space, Maxim Group analyst Jason McCarthy takes a look at small - cap companies targeting big - ticket indications and their potential to drive blockbuster value for both patients and invessmall - cap companies targeting big - ticket indications and their potential to drive blockbuster value for both patients and investors.

Finally, this ETF tends to focus on buying and holding mostly small cap biotech stocks, as the average company in this ETF has a market cap of roughly $ 2 billion, which is dwarfed but its category average market cap, which rings in closer to $ 35 billion.

While I tend to like ETFs that use equal weighing, it's important for investors to understand that smaller - cap companies tend to be a bit more volatile, and that's especially true of biotech stocks, which means this ETF might be more prone to even more volatility than a weighted - average ETF would be.

In a small biotech firm, by contrast, «you are part of the whole picture and you're more involved in what goes on in the entire company.»

The move followed the company's acquisition of another biotech, KuDOS Pharmacetuicals, in 2005 and several agreements with small biotechs to co-develop drugs.

But the aspect of the work I enjoy most, and one that I think differentiates research in a small biotech company from research in larger institutions and a great many university departments, is that competition is replaced by cooperation.

«In terms of learning potential, I thought that there would be more to learn in a small biotech company than in big pharma,» he explains.

The reality of the job market is that biotech companies hire in very specialized niches, and smaller fields such as bioinformatics have subcategories of their own.

The site was updated weekly and contained URLs for jobs sites from universities, colleges, hospitals, museums, companies (large and small, including biotech firms), government agencies, and all kinds of publications that advertise scientific jobs.

Secondly, he advises, take advantage of the fact that a lot of biotech companies are still small, open, and informal.

It's not big pharmaceutical companies driving the demand there, he says, but small biotech companies who've realized they can capitalize on the enormous amount of publicly available health and genomics data.

A study by UK - based Critical Limited, a consulting company, shows that while the number of biotech companies in Europe and the United States is almost equal, European companies are much smaller and have very few products in later stages.

You need that kind of communication just to get anything done in a small biotech company, says Douglas Gjerde, CEO of San Jose, California - based PhyNexus.

So, when I go to visit a small biotech company in California that is very casual, it makes sense to be in the same kind of attire.

Susan Schade, a UAB alumna who now does research for a small biotech company in Birmingham, says that the IR helped her in its «exposure to different career paths and networking» and allowed her «to make contact with all kinds of people not at UAB.»

The biotech industry in the other prairie province of Manitoba is comparatively small, with only six companies.

The biotech industry in Saskatchewan is centered in Saskatoon and is made up of mostly small (less than 50 employees) and medium - sized (between 50 and 150 employees) companies.

One of the most important ways they're doing this is by, in effect, outsourcing early - stage research and development to smaller pharma and biotech companies.

Sure, the smaller biotech companies can be squirrelly at times, but nothing beats the odd behavior of some Fortune 100 companies.

Efforts to inhibit this enzyme, called β - secretase 1 (BACE1), with small molecule drugs have met with limited success so far, says Ryan Watts, a neurobiologist at the biotech company Genentech in South San Francisco, California, and one of the leaders of the new research.

But because they're a small biotech company, with high risk of default (i.e., a high risk of not paying off their debts), they would have to pay a very high interest rate in order to make the bond attractive enough for investors to purchase it.

He predicts that the small but potent research community of universities and biotech companies centered in St. Louis and Kansas City will benefit from passage of the amendment — which prevents lawmakers from barring work on embryonic stem cells while criminalizing cloning with the goal of reproduction — as will patients.

These include government or private nonprofit funders of basic research, such as the National Institutes of Health in the United States or the Wellcome Trust in the United Kingdom; academic scientists; multinational pharmaceutical firms and smaller biotech companies; and, at the end of the line, government regulatory agencies responsible for drug approval.

With more than 1,200 international actors from 35 + countries, such as big pharma, emerging and small biotech, diagnostics companies, pre-seed / seed / Series A investors, as well as professionals from tech transfer, academia and research institutions, BioFIT is the leading partnering event in Europe for technology transfer, academia - industry collaborations and early - stage innovations in the field of Life Sciences.

He has consulted for three major pharmaceutical companies and is currently on the scientific advisory boards of two small biotech firms.

Jörg has a proven ability of managing small companies, directing preclinical drug research and discovery, external collaborations and working in multinational environments in the biotech and pharmaceutical industry.

He served as Laboratory Director at biotech company, Prosetta Corporation, leading several small molecule drug discovery programs focused on viruses of interest to the United States Department of Defense.

Lipotype offers high quality lipid analysis services with its Lipotype Shotgun Lipidomics Technology for a wide range of customers and applications including biomarker identification for clinical researchers, pharma and biotech companies, functional food development for the food industry, claim support for the cosmetics industry, as well as for the small - scale profiling needs of academic researchers.

Around the same time the CIT deal was playing out, Klarman took a sizable stake in Facet Biotech — a small biotech company spun off in December 2008 from PDL BioPharma — for an average cost of $ 9 even though it had $ 17 per share in net cash at the time of the spinoff.

COO / CFO / VP of Finance for small to mid-size company in the semiconductor, aerospace defense, pharmaceutical, biotech or renewable energy industry.